Paranthaman Modagan, Angu Bala Ganesh K S V, Silambanan Santhi
Department of Biochemistry, Dhanalakshmi Srinivasan Medical College and Hospital, Affiliated to The Tamilnadu Dr MGR Medical University, Perambalur 621 113, Tamil Nadu, India.
Department of Anatomy, Gujarat Adani Institute of Medical Science, Bhuj, Gujarat 370001, India.
Bioinformation. 2024 Jan 31;20(1):49-54. doi: 10.6026/973206300200049. eCollection 2024.
Osteoporosis is a systemic skeletal disorder with low-bone mass causing micro-architectural deterioration and an increase in bone fragility and susceptibility to fractures. According to a worldwide report by IOF, 1 in 3 females and 1 in 5 males will experience fractures due to the osteoporotic changes in their bones. Fractures may be the first clinical manifestation of the disease. They have been causes for morbidity and mortality imposing economic burden to osteoporosis. Bone marrow fat is a negative regulator of bone-turnover and a key integrator of bone and energy metabolism. Hence we assess the bone marrow fat and BMD in patients with osteoporotic bone fractures. This cross-sectional study was conducted in 30 patients from the department of orthopaedic surgery. Biopsy samples were received from excised bone during surgery. Biochemical parameters and bone marrow fat were quantified by established methods. A negative correlation between BMD versus serum adiponectin, FGF21 and similar observation with BMD versus bone marrow fat is seen. Therefore, increased bone-marrow fat and adiponectin, FGF21 levels and decreased BMD in osteoporosis. This observation might be useful for prevention, management and therapeutic potential of osteoporosis. Based on our study findings, understand the bone-fat relationship to implications with low BMD in patients with osteoporosis.
骨质疏松症是一种全身性骨骼疾病,骨量低会导致微观结构恶化,增加骨骼脆性和骨折易感性。根据国际骨质疏松基金会的一份全球报告,三分之一的女性和五分之一的男性会因骨骼的骨质疏松性变化而发生骨折。骨折可能是该疾病的首发临床表现。它们一直是导致发病和死亡的原因,给骨质疏松症带来经济负担。骨髓脂肪是骨转换的负调节因子,也是骨与能量代谢的关键整合者。因此,我们评估了骨质疏松性骨折患者的骨髓脂肪和骨密度。这项横断面研究对30名骨科手术患者进行。手术期间从切除的骨组织中获取活检样本。通过既定方法对生化参数和骨髓脂肪进行定量。观察到骨密度与血清脂联素、成纤维细胞生长因子21呈负相关,骨密度与骨髓脂肪也有类似观察结果。因此,骨质疏松症患者骨髓脂肪增加,脂联素、成纤维细胞生长因子21水平升高,骨密度降低。这一观察结果可能对骨质疏松症的预防、管理和治疗潜力具有重要意义。基于我们的研究结果,了解骨与脂肪的关系对骨质疏松症患者低骨密度的影响。